X4 Pharmaceuticals Inc
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 6.6 | – | – | 3.3 | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | 26.4 | 50.3 | 66.7 | 62.1 | 45.5 | 43.0 | – | – | – | – | – | – | – | – | – | – | – | 54.5 | 91.5 | 32.1 | 32.1 | 58.3 | 1.6 | 0.4 | 4.3 | 12.6 | 57.4 | 37.5 | |
| – | – | – | – | – | 0.2 | 0.0 | 0.0 | 0.2 | 32.9 | 1.0 | 2.1 | 2.3 | 1.4 | 1.7 | 1.8 | 1.5 | 1.8 | 1.7 | 1.9 | 2.1 | 1.0 | 1.2 | 1.1 | 2.3 | 1.4 | 2.5 | 4.7 | 3.2 | 3.3 | 270.3 | 1.2 | 2.3 | 6.7 | 2.1 | 3.5 | 2.4 | 2.4 | 3.1 | 3.8 | |
| – | – | – | – | – | – | – | – | – | – | – | – | 18.5 | 20.3 | 37.1 | 36.3 | 24.7 | 28.0 | – | – | – | – | – | – | – | – | – | – | – | 40.2 | 90.0 | 12.5 | 27.1 | 66.5 | 2.7 | 1.6 | 4.6 | 8.6 | 41.9 | 30.0 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.7 | – | – | 3.4 | – | – | – | – | – | |
| – | – | – | – | – | -196.6% | -2,091.7% | -15,871.0% | -1,028.0% | -5.5% | -129.5% | -20.0% | -24.7% | -27.4% | -26.3% | -26.7% | -37.9% | -46.6% | -35.3% | -41.1% | -49.8% | -107.2% | -119.9% | -210.7% | -54.5% | -77.2% | -61.7% | -25.4% | -38.2% | -54.9% | -37.0% | -96.8% | -93.7% | -88.1% | -232.2% | -798.2% | -72.1% | -20.0% | -17.9% | -17.4% | |
| Margins | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | -1.4% | -7.3% | 92.1% | 85.3% | 72.4% | 65.5% | – | – | – | – | – | – | – | – | – | – | – | -52.0% | -37.3% | -14.5% | 5.5% | 55.7% | 80.6% | 81.4% | 81.8% | 82.2% | 79.4% | 81.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | -641.1% | -1,365.8% | -1,598.2% | -1,639.7% | -1,773.3% | -1,995.8% | – | – | – | – | – | – | – | – | – | – | – | -3,513.8% | -3,774.7% | -3,411.5% | -3,129.0% | -5,530.0% | -362.1% | -323.1% | -291.1% | -247.4% | -1,084.4% | -554.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | -760.7% | -1,508.8% | -1,769.1% | -1,827.8% | -1,818.9% | -2,071.0% | – | – | – | – | – | – | – | – | – | – | – | -3,306.1% | -4,212.8% | 486.7% | -400.6% | -1,464.6% | 46.5% | -311.1% | -279.9% | -225.6% | -1,106.3% | -568.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | -651.8% | -1,377.7% | -1,751.7% | -1,657.6% | -1,723.3% | -2,006.0% | – | – | – | – | – | – | – | – | – | – | – | -2,989.7% | -3,389.1% | -3,110.3% | -3,011.5% | -5,132.1% | -360.1% | -343.0% | -312.3% | -252.4% | -1,030.1% | -652.1% | |
| Returns | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | -242.1% | -57.7% | -74.1% | -95.8% | -119.0% | -154.1% | -125.0% | -45.9% | -67.3% | -40.9% | -44.7% | -52.3% | -60.8% | -85.3% | -65.1% | -83.1% | -112.0% | -137.7% | -185.0% | -311.1% | -153.6% | -126.8% | -185.6% | -193.1% | -164.4% | -198.0% | -12,443.3% | 18.7% | -28.1% | -169.1% | 63.6% | -2,568.0% | -154.3% | -42.5% | -59.2% | -58.0% | |
| – | – | – | – | -75.4% | -41.7% | -51.8% | -63.3% | -72.3% | -92.4% | -58.8% | -33.1% | -48.6% | -32.9% | -34.5% | -38.5% | -41.0% | -50.6% | -43.3% | -52.4% | -63.8% | -75.7% | -92.3% | -115.5% | -83.7% | -60.3% | -77.1% | -75.2% | -64.1% | -68.7% | -114.9% | 8.4% | -9.4% | -25.6% | 11.2% | -97.0% | -58.1% | -27.3% | -36.9% | -35.6% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||||||||||||
| – | 2.1 | 6.5 | -30 | -29 | -70 | -62 | -47 | -38 | -21 | -2.8 | -67 | -55 | -105 | -89 | -77 | -63 | -45 | -81 | -61 | -42 | -47 | -32 | -13 | -45 | -87 | -60 | -103 | -76 | -44 | -4.5 | -71 | -21 | 21 | 37 | 38 | 7.6 | -140 | -140 | -118 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -2.7 | – | – | 1.5 | – | – | – | – | – | |
| – | -743.8% | -200.5% | 45.8% | 31.1% | 72.3% | 70.0% | 66.0% | 60.8% | 60.0% | 47.1% | 72.0% | 72.2% | 80.4% | 77.3% | 73.6% | 67.4% | 59.2% | 66.4% | 63.0% | 57.0% | 55.0% | 49.9% | 37.1% | 54.5% | 47.6% | 41.5% | 38.9% | 39.0% | 34.7% | 0.9% | 44.8% | 33.5% | 15.1% | 17.6% | 3.8% | 37.7% | 64.1% | 62.3% | 61.4% | |
| – | – | – | 0.1 | 0.2 | 0.1 | 0.0 | 0.1 | 0.1 | 0.5 | 0.7 | 0.3 | 0.3 | 0.2 | 0.2 | 0.3 | 0.3 | 0.5 | 0.3 | 0.4 | 0.5 | 0.5 | 0.7 | 1.1 | 0.6 | 0.5 | 0.6 | 0.5 | 0.8 | 1.1 | 54.0 | 0.8 | 1.3 | 3.5 | 3.4 | 19.4 | 1.3 | 0.4 | 0.5 | 0.5 | |
| Per Share | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | -58,867.66 | -5,497.73 | -84,563.14 | -85,200.36 | -2,169.42 | -19.38 | -642.53 | -100.49 | -109.71 | -96.21 | -79.55 | -82.12 | -81.51 | -92.39 | -100.72 | -83.87 | -86.69 | -91.72 | -81.80 | -79.20 | -34.24 | -27.95 | -19.71 | -23.19 | -16.93 | -15.27 | -19.34 | 2.63 | -2.50 | -5.54 | 2.13 | -13.76 | -2.20 | -0.72 | -0.79 | -0.71 | |
| – | – | – | – | – | – | – | – | – | – | – | – | 14.42 | 6.38 | 4.50 | 4.49 | 4.48 | 4.46 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.46 | 0.46 | 0.54 | 0.62 | 0.38 | 4.57 | 4.42 | 0.79 | 0.32 | 0.07 | 0.13 | |
| – | -4,273.67 | -1,662.94 | 1,368.19 | 24,313.31 | 9,527.26 | 114,191.72 | 88,910.86 | 1,823.45 | 12.57 | 514.16 | 218.94 | 162.97 | 235.43 | 178.06 | 157.07 | 133.99 | 108.26 | 154.60 | 100.89 | 77.43 | 66.61 | 44.21 | 25.46 | 22.30 | 22.05 | 10.62 | 12.01 | 10.29 | 7.71 | 0.16 | 14.11 | 8.90 | 3.27 | 3.34 | 0.54 | 1.42 | 1.69 | 1.33 | 1.23 | |
| – | – | – | – | -38,219.53 | -4,529.86 | -86,220.96 | -102,844.09 | -2,960.65 | -22.78 | -676.07 | -89.92 | -94.00 | -87.85 | -78.77 | -74.47 | -77.22 | -89.49 | -91.14 | -80.13 | -79.21 | -73.96 | -64.76 | -61.00 | -27.81 | -22.99 | -16.11 | -14.46 | -12.61 | -13.81 | -15.56 | -16.84 | -18.81 | -19.40 | -16.44 | -15.17 | -2.45 | -0.80 | -0.74 | -0.82 | |
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.